Stocks
Anika Therapeutics (ANIK) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -2.82% | 16.0% | 12.5% | 2.52% | -4.72% | -5.70% | ||
| Changes by years, y/y, % | -2pp | +19pp | -3pp | -10pp | -7pp | +43.7% | |||
Anika Therapeutics. EBITDA margin, %
Anika Therapeutics. EBITDA margin, changes, pp
Anika Therapeutics (ANIK) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -10.3% | -9.50% | -6.59% | 6.42% | -13.8% | -5.70% | |
| Changes by years, y/y, % | -6pp | -10pp | +59pp | -2 050pp | -3pp | |||
| Changes by quarters, q/q, % | -2 067pp | +1pp | +3pp | +13pp | -20pp | |||
